NCT02705105 2024-04-25Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid TumorsKyowa Kirin Co., Ltd.Phase 1/2 Completed114 enrolled 19 charts
NCT03633110 2022-04-19Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted VaccineGenocea Biosciences, Inc.Phase 1/2 Completed24 enrolled
NCT03544723 2020-06-09Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.MultiVir, Inc.Phase 2 Unknown40 enrolled